Semaglutide vs. Tirzepatide: How to Choose the Right GLP-1 for You

If you've started researching GLP-1 treatment, you've run into the two names that dominate the conversation: semaglutide and tirzepatide. They're related, they're both used for weight management, and they are not interchangeable.

The honest answer to "which one is better?" is: it depends on you. The right fit comes down to your health profile, your goals, how your body tolerates treatment, and — ultimately — a licensed physician's approval. Here's what actually separates the two, so you can choose with your eyes open.

How each one works

Both medications are injectables that act on gut hormones your body already uses to regulate appetite and blood sugar. The difference is how many pathways they hit.

• Semaglutide is a GLP-1 receptor agonist. It mimics one hormone — GLP-1 — to reduce appetite, slow how fast your stomach empties, and quiet the "food noise" that drives overeating.
• Tirzepatide is a dual GIP/GLP-1 agonist. It acts on GLP-1 and a second hormone, GIP. That dual action tends to produce stronger appetite control and metabolic effects for many people.

Think of semaglutide as a well-established single-target medication and tirzepatide as a newer dual-target one. Both are effective; they simply work through a different number of levers.

What the trials show

In clinical trials, both drove significant average weight loss over roughly a year of treatment, with tirzepatide generally showing the larger average reduction:

• Semaglutide produced average body-weight reductions in the mid-teens percent range in its major weight-management trials.
• Tirzepatide produced larger average reductions — into the low-twenties percent range at higher doses in its trials.

Two caveats matter more than the numbers. First, these are averages — individual results vary widely. Second, the "stronger" option isn't automatically the right one for you; tolerance, side effects, health history, and goals all weigh in. The GLP Journal keeps the fully-sourced trial breakdowns here: Semaglutide and Tirzepatide.

Side effects and tolerance

Both medications share a similar side-effect profile, most commonly gastrointestinal — nausea, reduced appetite, and digestive changes, especially early on as the dose increases. For most people these ease with time and careful titration.

This is exactly why dose matters as much as drug. Starting low and titrating slowly under physician direction is how tolerance is managed. A medication you can actually stay on beats a stronger one you have to quit.

How it works at LunaRx

With telehealth, you're in the driver's seat: you choose the GLP-1 you're interested in, and a licensed physician reviews your health profile and approves or denies it. Here's the path:

1. 1.Assess. You complete a secure online intake — in English or Spanish — covering your health history, your goals, and the medication you're interested in.
2. 2.Physician review. A licensed physician reviews your intake and either approves your treatment — with a starting dose calibrated to you — or, if it isn't the right fit, lets you know. You're only charged if you're approved.
3. 3.Recompose. Once approved, your GLP-1 is paired with muscle-protective peptides so you lose fat while lean mass is defended.
4. 4.Titrate. Your dose is adjusted over time based on how you respond and tolerate treatment.

Both semaglutide and tirzepatide are offered as precision-compounded, physician-directed protocols — compounded in the U.S. by 503A or 503B compounding pharmacies. The goal is simple: the right treatment for you, at a dose you can stay on successfully.

Frequently asked questions

Is tirzepatide better than semaglutide?

On average, tirzepatide showed larger weight loss in trials. "Better for you" depends on your health profile, tolerance, and goals — which is why every treatment is reviewed and approved by a licensed physician.

Can I switch between them?

Sometimes, based on how you respond. A switch is reviewed and approved by your physician.

Which has fewer side effects?

Their side-effect profiles are broadly similar and mostly gastrointestinal. Slow, physician-directed titration is the main lever for managing them.

How do I get started?

Complete the online eligibility check and tell us which GLP-1 you're interested in. A licensed physician reviews your profile and approves or denies treatment. Individual results vary, and there's $0 charge if you're not approved.

Ready to start? It takes about 3 minutes.

You don't have to decode the research alone. Choose the GLP-1 you're interested in, and a quick eligibility check puts your profile in front of a licensed physician who approves your treatment and a starting dose calibrated to you.

Check your eligibility in about 3 minutes — in English or Spanish. $0 if you're not approved.